|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I saw his lecture in person at ASCO. While listening I couldn't help but think that the perception of when to enroll in clinical trials needs to change. Most people think of it as the last resort. I was offered and enrolled in a phase I clinical trial when I was initially treated for ovarian cancer in 2005 . I knew that what I was taking was not going to be looked at in terms of benefit to me but rather the best level for future testing.I read about the agent and its use with other cancers and I figured if it wasn't going to hurt me why not take it. Sure it meant extra blood draws and visits to the clinic but I looked at that as a bonus since I had extra people watching and responding to what was happening to me.
ReplyDelete
I saw his lecture in person at ASCO. While listening I couldn't help but think that the perception of when to enroll in clinical trials needs to change. Most people think of it as the last resort. I was offered and enrolled in a phase I clinical trial when I was initially treated for ovarian cancer in 2005 . I knew that what I was taking was not going to be looked at in terms of benefit to me but rather the best level for future testing.I read about the agent and its use with other cancers and I figured if it wasn't going to hurt me why not take it. Sure it meant extra blood draws and visits to the clinic but I looked at that as a bonus since I had extra people watching and responding to what was happening to me.
ReplyDelete